High-pressure drug-coated balloon angioplasty (APERTO OTW ® ) without pre-dilatation for hemodialysis fistula stenosis: Midterm outcomes in 150 patients
The Journal of Vascular Access · 2026
DOI: 10.1177/11297298261452708 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von José García-Medina und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Interventional Radiology, Hospital General Universitario Rena Sofía, Murcia, Spain. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Arteriovenous Shunt, Surgical, Renal Dialysis, Coated Materials, Biocompatible. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Arteriovenous fistula stenosis is a major cause of access dysfunction in patients undergoing hemodialysis. Drug-coated balloons are a promising therapeutic option. This study evaluated the efficacy and safety of a high-pressure paclitaxel-coated balloon (APERTO OTW Cardionovum GmbH, Bonn, Germany) as a stand-alone treatment device without prior pre-dilatation.
Methods
A total of 168 angioplasties were performed using APERTO OTW in 150 patients. The mean follow-up was 15 months (range: 1–113). Most patients (89.3%) required only one intervention, with a mean of 1.13 interventions per patient (±0.38). De novo lesions accounted for 85.8% of cases.
Results
No device-related adverse events were observed. Vessel rupture was the most common complication (3.6%). The mean blood flow increased by 300.6 mL/min postoperatively. At follow-up, 37.5% of the fistulas remained functional, 26.8% required reintervention but remained patent, 28.6% progressed to non-salvageable thrombosis, and 7.1% underwent kidney transplantation with a functioning fistula. Overall patency rates at 6, 12, and 24 months were 81.54%, 61.3%, and 46.81%, respectively. Patency did not differ significantly between the de novo and previously treated lesions.
Conclusion
Angioplasty with the APERTO OTW drug-coated balloon, applied as a single high-pressure step without pre-dilatation, proved safe, effective, and complication-free. It significantly improved blood flow and maintained competitive long-term patency, confirming its reliability for hemodialysis vascular access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular and Interventional Radiology, Hospital General Universitario Rena Sofía, Murcia, Spain.
- Department of Dermatology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
- Department of Internal Medicine, Hospital Royo Vilanova, Zaragoza, Spain.
ORCID-Profile: José García-Medina
Zitieren
APA
García-Medina, J., García-Alfonso, J. J., & Bernal-Jiménez, R. (2026). High-pressure drug-coated balloon angioplasty (APERTO OTW ® ) without pre-dilatation for hemodialysis fistula stenosis: Midterm outcomes in 150 patients. The Journal of Vascular Access. https://doi.org/10.1177/11297298261452708
Vancouver
García-Medina J, García-Alfonso JJ, Bernal-Jiménez R. High-pressure drug-coated balloon angioplasty (APERTO OTW ® ) without pre-dilatation for hemodialysis fistula stenosis: Midterm outcomes in 150 patients. The Journal of Vascular Access. 2026. doi:10.1177/11297298261452708
BibTeX
@article{GarcaMedina2026,
author = {García-Medina, José and García-Alfonso, Juan José and Bernal-Jiménez, Raquel},
title = {High-pressure drug-coated balloon angioplasty (APERTO OTW ® ) without pre-dilatation for hemodialysis fistula stenosis: Midterm outcomes in 150 patients},
journal = {The Journal of Vascular Access},
year = {2026},
doi = {10.1177/11297298261452708}
}
EUVIMED